India’s Zydus Lifesciences posts lower profit as expenses outpace revenue growth

Nov 4 (Reuters) – Indian drugmaker Zydus Lifesciences reported a 26.6% fall in second-quarter profit on Wednesday, as rising expenses outweighed stronger demand, pushing its shares about 4% lower. Consolidated net profit fell to 9.26 billion rupees ($97.77 million) for the July-September quarter from 12.61 billion rupees a year earlier. Here are more details: • Total revenue rose 29.2%…

Open True Mainstream to compare left, right, and center coverage

1,600+ newsrooms tracked, in English, around the clock. Real newsrooms only — no NGOs, no press releases. Left/Right tags come from reader feedback. No algorithmic feed.